GenBioPro Suit Against FDA May Preserve Generic Mifepristone Approval
Generic Sales To Be Banned On 21 April Without Supreme Court Intervention
GenBioPro has filed a lawsuit against the FDA to try and preserve the approval of its generic mifepristone product, should the Supreme Court allow an order from a Texas judge to overrule the Food and Drug Administration’s approval of the drug.
